WINDTREE THERAPEUTICS INC /DE/
Cash Flow Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.8M | $-20.3M | $-39.2M | $-67.6M | $-32.6M | $-27.5M | $-20.5M | $-18.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | $192.0K |
| Depreciation | $84.0K | $82.0K | $533.0K | $192.0K | $168.0K | $195.0K | $160.0K | $192.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-15.4M | $-13.4M | $-19.5M | $-23.7M | $-25.3M | $-24.7M | $-15.8M | $-21.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $12.0K | $15.0K | $13.0K | $279.0K | $291.0K | $191.0K | — | $24.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-12.0K | $-15.0K | $197.0K | $-279.0K | $-291.0K | $13.8M | $-13.7M | $-24.0K |
| Financing Activities | ||||||||
| Dividends Paid | $657.0K | $0 | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.7M | $11.6M | $3.1M | $29.4M | $20.0M | $21.8M | $38.7M | $17.3M |
| Net Change in Cash | $-2.7M | $-1.9M | $-16.2M | $5.4M | $-5.6M | $11.4M | $9.3M | $-3.8M |
| Free Cash Flow | $-15.4M | $-13.5M | $-19.5M | $-23.9M | $-25.6M | $-24.9M | — | $-21.1M |